Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot Symptoms [NA]

View source ↗

Summary

An open-label pilot trial completed to assess whether Magic Foot™ improves foot-related parameters in people with diabetes and peripheral vascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magic Foot™

Snippet

Sponsor: Yaffa Golan, Ltd. | Conditions: Diabetes, Peripheral Vascular Disease | NA | Status: COMPLETED